Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IPPK | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | CYB561A3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | NIF3L1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SPATA2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | RPS11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
mRNA | RUSC1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | SLFN12L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PAQR6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | CERS2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SUCLG1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |